News Website

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Business Wire

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Business Wire

Published: Oct. 27, 2025, 7:33 p.m.

Read Full Article

CHOORO Yellow Awareness Ribbon Charm Earrings Cancer Awareness Jewelry Gift for Endometriosis/Bladder Cancer/Suicide Prevention/Bone Cancer - The San Joaquin Valley Sun

CHOORO Yellow Awareness Ribbon Charm Earrings Cancer Awareness Jewelry Gift for Endometriosis/Bladder Cancer/Suicide Prevention/Bone Cancer The San Joaquin Valley Sun

Published: Oct. 27, 2025, 6:21 p.m.

Read Full Article

Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment - TipRanks

Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment TipRanks

Published: Oct. 27, 2025, 5:04 p.m.

Read Full Article

Predicted peptide scaffolds for drug screening in endometrial cancer organoids - Nature

Predicted peptide scaffolds for drug screening in endometrial cancer organoids Nature

Published: Oct. 27, 2025, 2:22 p.m.

Read Full Article

Diagnostic Accuracy of Endometrial Sampling Methods for Determining Histologic Type and Grade in Endometrial Cancer: A Retrospective Cohort Study - Cureus

Diagnostic Accuracy of Endometrial Sampling Methods for Determining Histologic Type and Grade in Endometrial Cancer: A Retrospective Cohort Study Cureus

Published: Oct. 26, 2025, 10:10 a.m.

Read Full Article

Researchers identify common painkiller that may prevent endometrial cancer - Daily Nation

Researchers identify common painkiller that may prevent endometrial cancer Daily Nation

Published: Oct. 26, 2025, 10 a.m.

Read Full Article

Correction: Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis - Cell Communication and Signaling

Correction: Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis Cell Communication and Signaling

Published: Oct. 24, 2025, 12:50 p.m.

Read Full Article

Every Woman: Breast Cancer Awareness - FRCN HQ

Every Woman: Breast Cancer Awareness FRCN HQ

Published: Oct. 23, 2025, 10:43 p.m.

Read Full Article

WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer - OncLive

WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer OncLive

Published: Oct. 23, 2025, 6:03 p.m.

Read Full Article

Rising Cancer Rates Among Young Adults Spur Global Alarm - Evrim Ağacı

Rising Cancer Rates Among Young Adults Spur Global Alarm Evrim Ağacı

Published: Oct. 23, 2025, 2:54 a.m.

Read Full Article

Latest Articles

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Business Wire

CHOORO Yellow Awareness Ribbon Charm Earrings Cancer Awareness Jewelry Gift for Endometriosis/Bladder Cancer/Suicide Prevention/Bone Cancer - The San Joaquin Valley Sun

Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment - TipRanks

Predicted peptide scaffolds for drug screening in endometrial cancer organoids - Nature

Diagnostic Accuracy of Endometrial Sampling Methods for Determining Histologic Type and Grade in Endometrial Cancer: A Retrospective Cohort Study - Cureus

Researchers identify common painkiller that may prevent endometrial cancer - Daily Nation

Correction: Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis - Cell Communication and Signaling

Every Woman: Breast Cancer Awareness - FRCN HQ

WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer - OncLive

Rising Cancer Rates Among Young Adults Spur Global Alarm - Evrim Ağacı

Subscribe to Our Newsletter